| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Receptor Substrate Proteins | 17 | 2024 | 58 | 5.730 |
Why?
|
| Breast Neoplasms | 24 | 2021 | 1129 | 2.870 |
Why?
|
| Signal Transduction | 19 | 2022 | 2887 | 1.850 |
Why?
|
| Phosphoproteins | 7 | 2019 | 211 | 1.580 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2021 | 185 | 1.460 |
Why?
|
| Neoplasm Invasiveness | 14 | 2018 | 243 | 1.410 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 276 | 1.330 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2018 | 62 | 1.080 |
Why?
|
| Integrins | 10 | 2002 | 106 | 1.070 |
Why?
|
| Neoplasms | 5 | 2022 | 1244 | 1.050 |
Why?
|
| Indoleacetic Acids | 1 | 2024 | 31 | 0.930 |
Why?
|
| Integrin alpha6beta4 | 7 | 2010 | 44 | 0.850 |
Why?
|
| Somatomedins | 1 | 2022 | 4 | 0.840 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2021 | 83 | 0.820 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2022 | 168 | 0.810 |
Why?
|
| Cell Line, Tumor | 15 | 2020 | 1374 | 0.810 |
Why?
|
| Beclin-1 | 2 | 2019 | 20 | 0.800 |
Why?
|
| Receptors, Somatomedin | 2 | 2018 | 10 | 0.750 |
Why?
|
| Cognitive Dysfunction | 5 | 2024 | 262 | 0.740 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2021 | 20 | 0.740 |
Why?
|
| Phosphatidylinositol 3-Kinase | 2 | 2022 | 13 | 0.670 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 53 | 0.650 |
Why?
|
| Endosomes | 2 | 2019 | 169 | 0.630 |
Why?
|
| Receptor, IGF Type 1 | 4 | 2021 | 30 | 0.630 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 555 | 0.620 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 23 | 0.590 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 139 | 0.590 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 234 | 0.570 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 556 | 0.560 |
Why?
|
| Phosphorylation | 11 | 2017 | 859 | 0.560 |
Why?
|
| Tyrosine | 5 | 2017 | 93 | 0.510 |
Why?
|
| Microtubules | 1 | 2017 | 211 | 0.500 |
Why?
|
| Receptors, Growth Factor | 1 | 2015 | 20 | 0.490 |
Why?
|
| Humans | 48 | 2024 | 59471 | 0.470 |
Why?
|
| Glucose | 3 | 2018 | 444 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2019 | 483 | 0.460 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 148 | 0.460 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 41 | 0.450 |
Why?
|
| Glycolysis | 1 | 2014 | 54 | 0.450 |
Why?
|
| Amyloid beta-Peptides | 5 | 2024 | 194 | 0.450 |
Why?
|
| Antigens, Surface | 4 | 2002 | 191 | 0.410 |
Why?
|
| Female | 27 | 2021 | 30895 | 0.410 |
Why?
|
| Cell Membrane | 2 | 2011 | 492 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2010 | 7 | 0.360 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2010 | 17 | 0.360 |
Why?
|
| Laminin | 5 | 2005 | 74 | 0.360 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 45 | 0.360 |
Why?
|
| Cell Movement | 8 | 2015 | 423 | 0.360 |
Why?
|
| Neoplasm Metastasis | 3 | 2008 | 196 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2007 | 324 | 0.350 |
Why?
|
| Cell Proliferation | 5 | 2019 | 942 | 0.350 |
Why?
|
| Mice | 16 | 2020 | 10273 | 0.330 |
Why?
|
| Animals | 22 | 2020 | 19649 | 0.320 |
Why?
|
| Membrane Proteins | 1 | 2015 | 844 | 0.320 |
Why?
|
| Antigens, CD | 2 | 2021 | 343 | 0.320 |
Why?
|
| Neoplastic Stem Cells | 3 | 2022 | 201 | 0.310 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2008 | 50 | 0.310 |
Why?
|
| Biomarkers | 7 | 2024 | 1198 | 0.300 |
Why?
|
| Tumor Cells, Cultured | 8 | 2014 | 454 | 0.290 |
Why?
|
| Biomarkers, Tumor | 3 | 2017 | 453 | 0.280 |
Why?
|
| Disease Progression | 5 | 2022 | 1046 | 0.280 |
Why?
|
| Receptor, Insulin | 2 | 2021 | 47 | 0.270 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 30 | 0.270 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2009 | 113 | 0.260 |
Why?
|
| Apolipoprotein E4 | 2 | 2023 | 35 | 0.240 |
Why?
|
| Protein Transport | 4 | 2017 | 394 | 0.230 |
Why?
|
| Mice, Knockout | 4 | 2014 | 1988 | 0.220 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 454 | 0.220 |
Why?
|
| Proteolysis | 1 | 2024 | 137 | 0.220 |
Why?
|
| MicroRNAs | 1 | 2009 | 619 | 0.210 |
Why?
|
| Parkinson Disease | 1 | 2024 | 99 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 1223 | 0.210 |
Why?
|
| Cell Adhesion | 4 | 2001 | 209 | 0.210 |
Why?
|
| Aged | 8 | 2024 | 13342 | 0.210 |
Why?
|
| ErbB Receptors | 2 | 2019 | 113 | 0.210 |
Why?
|
| Neuroimaging | 2 | 2023 | 130 | 0.210 |
Why?
|
| Integrin alpha6beta1 | 5 | 2013 | 34 | 0.200 |
Why?
|
| HEK293 Cells | 1 | 2024 | 575 | 0.200 |
Why?
|
| Central Venous Catheters | 1 | 2022 | 17 | 0.200 |
Why?
|
| Catheter-Related Infections | 1 | 2022 | 40 | 0.200 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 70 | 0.190 |
Why?
|
| Collagen | 3 | 2005 | 116 | 0.190 |
Why?
|
| Protein Binding | 5 | 2014 | 1553 | 0.190 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 15 | 0.190 |
Why?
|
| Cell Survival | 5 | 2020 | 557 | 0.190 |
Why?
|
| Catheterization, Central Venous | 1 | 2022 | 87 | 0.190 |
Why?
|
| Bacteremia | 1 | 2022 | 93 | 0.190 |
Why?
|
| Perioperative Care | 1 | 2021 | 77 | 0.180 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 233 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2024 | 603 | 0.180 |
Why?
|
| Ethylene Glycols | 1 | 2020 | 6 | 0.180 |
Why?
|
| Aniline Compounds | 1 | 2020 | 29 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 327 | 0.180 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 161 | 0.180 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 13 | 0.180 |
Why?
|
| Amino Acid Motifs | 3 | 2014 | 153 | 0.180 |
Why?
|
| Enzyme Activation | 4 | 2010 | 353 | 0.170 |
Why?
|
| Selenium | 1 | 2020 | 25 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 90 | 0.170 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 35 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2015 | 1457 | 0.160 |
Why?
|
| Peptide Fragments | 1 | 2020 | 352 | 0.160 |
Why?
|
| Triglycerides | 1 | 2020 | 242 | 0.150 |
Why?
|
| Insulin | 1 | 2022 | 686 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 758 | 0.150 |
Why?
|
| Xanthines | 1 | 1998 | 7 | 0.150 |
Why?
|
| Middle Aged | 5 | 2024 | 16259 | 0.150 |
Why?
|
| Lymphoma, T-Cell | 1 | 1998 | 21 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 89 | 0.150 |
Why?
|
| Macrophages | 2 | 1994 | 1004 | 0.150 |
Why?
|
| Cytoskeleton | 2 | 2017 | 140 | 0.150 |
Why?
|
| Milk Proteins | 1 | 1998 | 45 | 0.150 |
Why?
|
| Receptors, Laminin | 2 | 1996 | 17 | 0.140 |
Why?
|
| tau Proteins | 3 | 2024 | 104 | 0.140 |
Why?
|
| Extracellular Matrix | 2 | 2005 | 130 | 0.140 |
Why?
|
| Lymph Nodes | 1 | 2018 | 212 | 0.140 |
Why?
|
| Survival Rate | 1 | 2019 | 790 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2018 | 179 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 1997 | 135 | 0.140 |
Why?
|
| Tubulin | 1 | 2017 | 74 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2017 | 90 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2014 | 305 | 0.130 |
Why?
|
| Prognosis | 3 | 2024 | 1572 | 0.130 |
Why?
|
| Trans-Activators | 1 | 1998 | 295 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2002 | 1131 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2022 | 6007 | 0.130 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 13 | 0.130 |
Why?
|
| Cell Line | 5 | 2008 | 2013 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2021 | 762 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 396 | 0.120 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 82 | 0.120 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2015 | 8 | 0.120 |
Why?
|
| Transfection | 5 | 2001 | 674 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2017 | 379 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 65 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 48 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 111 | 0.110 |
Why?
|
| src-Family Kinases | 3 | 2009 | 60 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2014 | 26 | 0.110 |
Why?
|
| Integrin alpha6 | 1 | 2014 | 19 | 0.110 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 1578 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2014 | 70 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2006 | 3193 | 0.110 |
Why?
|
| Male | 7 | 2024 | 27561 | 0.110 |
Why?
|
| Biological Transport | 1 | 2014 | 287 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2001 | 166 | 0.110 |
Why?
|
| Cytoplasm | 4 | 2002 | 273 | 0.110 |
Why?
|
| Models, Biological | 1 | 2018 | 1141 | 0.110 |
Why?
|
| Base Sequence | 4 | 2004 | 1311 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 31 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2014 | 160 | 0.100 |
Why?
|
| Neuropilin-2 | 1 | 2013 | 39 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 2 | 2011 | 51 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 416 | 0.100 |
Why?
|
| DNA | 2 | 1993 | 792 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5098 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 664 | 0.090 |
Why?
|
| Vidarabine | 1 | 2010 | 5 | 0.090 |
Why?
|
| Busulfan | 1 | 2010 | 11 | 0.090 |
Why?
|
| Myeloablative Agonists | 1 | 2010 | 13 | 0.090 |
Why?
|
| Neoplasm Grading | 1 | 2011 | 74 | 0.090 |
Why?
|
| src Homology Domains | 1 | 2010 | 21 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 50 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 173 | 0.090 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 94 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2011 | 109 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 124 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 138 | 0.090 |
Why?
|
| Adult | 3 | 2019 | 15771 | 0.090 |
Why?
|
| Mutation | 1 | 2018 | 2445 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2009 | 1468 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2014 | 200 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 43 | 0.080 |
Why?
|
| S100 Proteins | 1 | 2009 | 21 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 387 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 123 | 0.080 |
Why?
|
| Aerobiosis | 1 | 2008 | 8 | 0.080 |
Why?
|
| Colonic Neoplasms | 3 | 2002 | 215 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 48 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 340 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2010 | 162 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 115 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 51 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 316 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 255 | 0.070 |
Why?
|
| Integrin beta4 | 1 | 2007 | 31 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 847 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 498 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 847 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2020 | 260 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 50 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2005 | 33 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2005 | 108 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2005 | 137 | 0.060 |
Why?
|
| Apoptosis | 3 | 2004 | 1038 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2008 | 709 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2004 | 28 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2004 | 20 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 178 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 98 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2004 | 79 | 0.050 |
Why?
|
| Mitosis | 1 | 2004 | 208 | 0.050 |
Why?
|
| GAP-43 Protein | 1 | 2022 | 2 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 11 | 0.050 |
Why?
|
| Endocytosis | 1 | 2004 | 148 | 0.050 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2002 | 2 | 0.050 |
Why?
|
| Dideoxynucleosides | 1 | 2002 | 9 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2002 | 32 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 63 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1488 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 21 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 66 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 32 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 137 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2001 | 48 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 79 | 0.050 |
Why?
|
| Genetic Variation | 2 | 1994 | 364 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2001 | 58 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2001 | 190 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 264 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2002 | 154 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 135 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 189 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2020 | 6 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2020 | 21 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 317 | 0.040 |
Why?
|
| Selenocysteine | 1 | 2020 | 14 | 0.040 |
Why?
|
| Selenium Compounds | 1 | 2020 | 29 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2001 | 214 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2000 | 5 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1993 | 1975 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 180 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 73 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 177 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2000 | 60 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 287 | 0.040 |
Why?
|
| RNA Interference | 2 | 2014 | 590 | 0.040 |
Why?
|
| Hippocampus | 1 | 2020 | 240 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1998 | 4 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 1998 | 14 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1997 | 8 | 0.040 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1997 | 14 | 0.040 |
Why?
|
| Androstadienes | 1 | 1997 | 30 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 80 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 227 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 376 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 667 | 0.030 |
Why?
|
| HIV-1 | 1 | 2002 | 705 | 0.030 |
Why?
|
| Carcinoma | 1 | 1997 | 117 | 0.030 |
Why?
|
| NFATC Transcription Factors | 2 | 2009 | 20 | 0.030 |
Why?
|
| Epitopes | 1 | 1997 | 295 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1225 | 0.030 |
Why?
|
| Cell Division | 1 | 1998 | 442 | 0.030 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 460 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2015 | 7 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 341 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 749 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2443 | 0.030 |
Why?
|
| Manganese | 1 | 1994 | 24 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2014 | 16 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2014 | 34 | 0.030 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Proteins | 1 | 2000 | 740 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3096 | 0.030 |
Why?
|
| Cell Communication | 1 | 1994 | 127 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 304 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 65 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1994 | 377 | 0.030 |
Why?
|
| Chickens | 1 | 1993 | 91 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1993 | 119 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 358 | 0.030 |
Why?
|
| Child | 1 | 2022 | 4308 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 385 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 645 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 243 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 511 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1991 | 12 | 0.020 |
Why?
|
| Cartilage | 1 | 1991 | 36 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2038 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 384 | 0.020 |
Why?
|
| Calcium | 1 | 1994 | 552 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 125 | 0.020 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 201 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 577 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 856 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 363 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 851 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 2007 | 6 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 328 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 251 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 155 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 501 | 0.020 |
Why?
|
| Cell Surface Extensions | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2004 | 19 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 21 | 0.010 |
Why?
|
| Feedback | 1 | 2003 | 87 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 165 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 176 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 21 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 16 | 0.010 |
Why?
|
| Polyribosomes | 1 | 2002 | 14 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2002 | 92 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 526 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 260 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 2002 | 70 | 0.010 |
Why?
|
| Tyrphostins | 1 | 2001 | 3 | 0.010 |
Why?
|
| Quinazolines | 1 | 2001 | 22 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 84 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 432 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 525 | 0.010 |
Why?
|
| Drug Resistance, Viral | 1 | 2002 | 155 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 133 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 323 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2000 | 3 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2000 | 8 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 149 | 0.010 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2000 | 9 | 0.010 |
Why?
|
| ras-GRF1 | 1 | 2000 | 3 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2000 | 14 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 55 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 2000 | 64 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 374 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 141 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2000 | 274 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 336 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1997 | 159 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 223 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 298 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2000 | 1294 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 1538 | 0.010 |
Why?
|